Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Journal of Clinical Psychopharmacology
|
October 25, 2011
Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients
Po-Hsiu Kuo, Chung-Feng Kao, Po-Yu Chen, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 7, 2019
Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication
Tzu-Hua Wu, Chih-Chiang Chiu, Kah Kheng Goh, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 27, 2024
Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
Po-Yu Chen, Chih-Chiang Chiu, Chin-Kuo Chang, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 8, 2025
Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
Tzu-Hua Wu, Shu-Chin Hu, Nailis Sylfa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 5, 2011
A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test
Chun-Hsin Chen, Tsang-Yaw Lin, Tzu-Ting Chen, et al.
Frontiers in Pharmacology
|
August 23, 2021
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
Tzu-Hua Wu, Chieh-Hsin Lin, Kah Kheng Goh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 7, 2024
Folate and vitamin B12 supplementation in patients with schizophrenia and low serum folate level: A 24-week randomized, double-blind, placebo-controlled study
Chun-Hsin Chen, Chih-Chiang Chiu, Yi-Hang Chiu, et al.
Psychoneuroendocrinology
|
May 20, 2022
The relationship of antipsychotic treatment with reduced brown adipose tissue activity in patients with schizophrenia
Po-Yu Chen, Chih-Chiang Chiu, Tsung-Han Hsieh, et al.
Journal of Clinical Psychopharmacology
|
August 12, 2015
The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia
Po-Yu Chen, Mong-Liang Lu, Ming-Chyi Huang, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2021
Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia
Chun-Hsin Chen, Po-Yu Chen, Cynthia Yi-An Chen, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Journal of Clinical Psychopharmacology
|
October 25, 2011
Polymorphisms of INSIG2, MC4R, and LEP are associated with obesity- and metabolic-related traits in schizophrenic patients
Po-Hsiu Kuo, Chung-Feng Kao, Po-Yu Chen, et al.
Journal of Psychopharmacology (Oxford, England)
|
November 7, 2019
Relationship between metabolic syndrome and acylated/desacylated ghrelin ratio in patients with schizophrenia under olanzapine medication
Tzu-Hua Wu, Chih-Chiang Chiu, Kah Kheng Goh, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 27, 2024
Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
Po-Yu Chen, Chih-Chiang Chiu, Chin-Kuo Chang, et al.
Journal of Psychopharmacology (Oxford, England)
|
January 8, 2025
Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study
Tzu-Hua Wu, Shu-Chin Hu, Nailis Sylfa, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
February 5, 2011
A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test
Chun-Hsin Chen, Tsang-Yaw Lin, Tzu-Ting Chen, et al.
Frontiers in Pharmacology
|
August 23, 2021
The Relationships Between Hyperprolactinemia, Metabolic Disturbance, and Sexual Dysfunction in Patients With Schizophrenia Under Olanzapine Treatment
Tzu-Hua Wu, Chieh-Hsin Lin, Kah Kheng Goh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
December 7, 2024
Folate and vitamin B12 supplementation in patients with schizophrenia and low serum folate level: A 24-week randomized, double-blind, placebo-controlled study
Chun-Hsin Chen, Chih-Chiang Chiu, Yi-Hang Chiu, et al.
Psychoneuroendocrinology
|
May 20, 2022
The relationship of antipsychotic treatment with reduced brown adipose tissue activity in patients with schizophrenia
Po-Yu Chen, Chih-Chiang Chiu, Tsung-Han Hsieh, et al.
Journal of Clinical Psychopharmacology
|
August 12, 2015
The Relationships of Obesity-Related Genetic Variants With Metabolic Profiles and Response to Metformin in Clozapine-Treated Patients With Schizophrenia
Po-Yu Chen, Mong-Liang Lu, Ming-Chyi Huang, et al.
International Journal of Environmental Research and Public Health
|
November 13, 2021
Associations of Genetic Variants of Methylenetetrahydrofolate Reductase and Serum Folate Levels with Metabolic Parameters in Patients with Schizophrenia
Chun-Hsin Chen, Po-Yu Chen, Cynthia Yi-An Chen, et al.
Page
of 11